Agenus, Inc. - AGEN Net Assets per Single Share

Graphic logo of Agenus (AGEN)

The price trend for Agenus (AGEN) is based on the authority of this biopharmaceutical giant, which develops unique therapy regimens to activate the body's defenses against tumors. The current indicator stands at -4.70. Agenus is outpacing its competitors due to high patient survival rates in colorectal cancer treatment. Growth is driven by partnerships with global corporations integrating the firm's antibodies into their protocols.

Agenus, Inc. (AGEN): Share Book Value from 07/04/2022 to 10/27/2026

agenusbio.com - analytical breakdowns and key metrics (AGEN)

- price and consensus price forecast:
Stock Price Agenus Inc|AGEN - Average Forecast Price
- market capitalization data:
Market Value Agenus Inc.|AGEN - Business Value
- book capitalization data:
Net Assets per Single Share Agenus|AGEN - Net Asset Value|Market Capitalization to Book Value Ratio agenusbio.com|AGEN - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Agenus|AGEN - Long-Term Debt to Capital|Short-Term Debt to Equity Agenus Inc.|AGEN - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Agenus Inc.
Fundamental company valuation:Agenus Inc - AGEN
Manufactured products of Agenus Inc.

For Agenus (AGEN), capital inflows from licensing agreements and milestones directly impact net assets, making the book value per share an indicator of financial stability for this biopharmaceutical leader. This metric is calculated as the difference between total assets and liabilities divided by the number of shares, reflecting the actual value of an investor's stake and the business's level of maturity through resource accumulation net of debt.

Competitors of Agenus (AGEN)

ARGX (Argenx) - Book Value per Share|BNTX: Net Asset Value per Share|Net Assets per Single Share Abivax Corp|ADMA (admabiologics.com) - Equity per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|Astria Pharma - Book Value per Share|ENGN - Book Value per Share|Book Value per Share RAPT (RAPT Therapeutics, Inc.)|Aerovate Therapeutics (JBIO) - Book Value of One Share|Book Value per Share ACRS (Aclaris Therapeutics, Inc.)|Net Asset Value per Share KYTX|Net Assets per Single Share Tiziana Life Sciences PLC TLSA|Equity per Share Cabaletta Bio Inc CABA|Accounting Value per Share VTYX (Ventyx Biosciences)|theratech.com - Book Value per Share|Net Assets per Single Share AVTX (Avalo Therapeutics)|ELDN - Net Assets per Share|CLYM: Book Value per Share|Zura Bio Ltd (ZURA) - Book Value per Share|aTyr Pharma, Inc. - Book Value per Share|Book Value of One Share Adagene Corp|ImageneBio Inc - Book Value per Share|Net Asset Value per Share STTK (shattucklabs.com)|EQ - Net Assets per Single Share|Connect Biopharma Holdings - Equity per Share|Net Assets per Single Share Immunic Inc|ATRA - Share Book Value|Book Value per Share inflarx.de IFRX|X4 Pharmaceuticals Inc. (XFOR) - Accounting Value of a Share|ACET (Adicet Bio Inc.) - Book Value per Share|Book Value per Share CELU|INmune Bio, Inc. (INMB) - Net Assets per Single Share|Accounting Value of a Share BRNS (barinthusbio.com)|Kezar Life Sciences, Inc. - Net Assets per Single Share|Accounting Value per Share SAB Biotherapeutics Inc. SABS|Akari Therapeutics plc - Book Value per Share|Enlivex Therapeutics (ENLV) - Book Value per Share|Accounting Value per Share q32bio.com QTTB|geovax.com (GOVX) - Accounting Value of a Share|EDSA: Book Value per Share|Net Assets per Share IBIO|Net Assets per Single Share CARM (Carisma Therapeutics)|Accounting Value per Share XTLB (XTL Bio)|Bolt Biotherapeutics, Inc. - Net Assets per Single Share|HCWB - Accounting Value per Share|Aptevo - Accounting Value per Share|AIM: Book Value per Share|Net Assets per Single Share aditxt.com|GRI Bio Corporation (GRI) - Equity per Share|Book Value per Share XRTX (XORTX Therapeutics Inc.)|Net Asset Value per Share reshapelifesciences.com|Book Value per Share REVB|Book Value per Share Indaptus Therapeutics Inc (INDP)|SCNI (Scinai) - Book Value per Share|Book Value of One Share CalciMedica Inc CALI|AFMD (Affimed Therapeutics) - Book Value per Share|ALLK: Net Asset Value per Share|Net Assets per Single Share hookipapharma.com|Equity per Share IGM Biosciences|ITOS (iTeos) - Accounting Value per Share|Book Value per Share OCEA|TCBP (TC Biopharm) - Net Assets per Single Share|Net Assets per Share thirdharmonicbio.com (THRD)